Asian press release distribution

Press Releases for Monday, January 30, 2023

Austral Gold Announces Drill Results at Casposo-Manantiales 21:30 HKT/SGT

顺丰同城亏损较去年同期减少50%以上规模效应优势逐步凸显 21:02 HKT/SGT

順豐同城虧損較去年同期減少50%以上規模效應優勢逐步凸顯 21:01 HKT/SGT

SF Intra-City reduced losses by over 50% year-over-year in 2022, Increasing benefits from scale effect 21:00 HKT/SGT

STGZ Partners with Klaytn to Scale Next Generation Metaverse Platform for Artists 20:31 HKT/SGT

三菱自、2022年12月単月、2022年暦年　生産・販売・輸出実績を発表 17:00 HKT/SGT

マツダ、2022年12月および1～12月の生産･販売状況について 17:00 HKT/SGT

横浜国立大学・NTTドコモ・日本電業工作・富士通、回路規模を約1/10に低減する高効率な5Gマルチセクタアンテナ屋内基地局装置を開発し、28GHz帯での世界初の実証実験に成功 17:00 HKT/SGT

DOCOMO Conducts World's First Trial of Transmissive Metasurface on Window to Deliver Indoor Radio Waves to Outdoor Foot of Building 16:00 HKT/SGT

Small, Efficient 5G Multisector Antenna Indoor Base Station Achieves World's First Demonstration using 28GHz 15:35 HKT/SGT

DOCOMO and YKK AP to Test Signal-permeable Windows Made with Aerogel for Easy Penetration by Radio Waves 15:13 HKT/SGT

Honda、2022年12月度四輪車生産・販売・輸出実績を発表 15:00 HKT/SGT

NEC announces plans for transition to a Company with a Nominating Committee, etc. and implementation of organizational reforms 14:44 HKT/SGT

NEC announces executive personnel changes 14:28 HKT/SGT

トヨタ、2022年年間（1月-12月）販売・生産・輸出実績を発表 13:30 HKT/SGT

LEXUS、2022年の全世界販売実績を発表 13:30 HKT/SGT

Toyota: Sales, Production, and Export Results for 2022 (January - December) 12:36 HKT/SGT

日立、日本・ASEANにおけるロボティクスSI事業の拡大に向けグループ会社2社を合併 12:00 HKT/SGT

Lecanemab Receives Priority Review Status in Japan 11:50 HKT/SGT

欧康维视生物分别任命阮添士先生及王冲先生为首席财务官及投资者关系负责人 11:40 HKT/SGT

歐康維視生物分別任命阮添士先生及王沖先生為首席財務官及投資者關係負責人 11:39 HKT/SGT

Ocumension Therapeutics Appoints Mr. Tim RUAN and Mr. WANG Chong as Chief Financial Officer and Head of Investor Relations respectively 11:38 HKT/SGT

President Joko Widodo Launches Indonesia's 2023 ASEAN Chairmanship 11:00 HKT/SGT

Two Hitachi Group Companies to Merge to Expand Robotic SI Business in Japan and ASEAN Countries 10:08 HKT/SGT

エーザイとバイオジェン、抗アミロイドβプロトフィブリル抗体「レカネマブ」について、日本において優先審査品目に指定 09:00 HKT/SGT

ACN Search:

TrustCSI 3.0 Navigates the 'Belt and Road' and Empowers Global Enterprise's Digital Journey


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575